Open navigation
Search
Search

Select your region

Languages
  • English
Social media

Theo is a Partner in CMS’s Corporate Group. He advises on a wide range of corporate transactions, including acquisitions, disposals, private equity and venture capital transactions and joint venture arrangements, for both private and listed clients. Theo has a particular focus on the Life Sciences & Healthcare, Technology, Media & Communications and Sports sectors.

Clients include established domestic and international companies, growing businesses, institutional investors, high net-worth individuals and management teams.

Theo co-manages CMS’s equIP programme, which supports early/growth stage business. 

Awards & Recognitions
01
  • Quote
    "Theo Godfrey is really helpful. He explains things very well, is always available to speak with us and somehow to accommodate urgent requests. He is very friendly and helpful and very keen to ensure the best outcome for the client."
    Legal 500, 2021
  • Quote
    “Experienced, market savvy, decisive”.
    Legal 500
  • Quote
    “Always on top of her subject”
    Legal 500
  • Quote
    “First class technical knowledge and communicates effectively”

Relevant experience

  • Syncona, the LSE listed life sciences investment fund, on its $475m disposal of diagnostic imaging business Blue Earth Diagnostics to Bracco lmaging.
  • Essential Pharmaceuticals, a pharma business, on the sale to Rosemont Pharmaceuticals of its oral liquids portfolio and the acquisition from Rosemont Pharmaceuticals of a portfolio of products, in each case through a new corporate vehicle.
  • Contura on the sale to Axonics of Bulkamid, a treatment for stress urinary incontinence, for $200m in upfront consideration plus deferred consideration of up to $35m, payable in a combination of cash and Axonics stock.
  • Contura on its acquisition of Innovative Medical Solutions.
  • Catalent, lnc., a NYSE listed provider of drug delivery technology and development solutions, on  the UK aspects of its $140m acquisition of Juniper Pharmaceuticals, lnc., a NASDAQ listed provider of women´s health therapeutics.
  • The Crick lnstitute, a biomedical discovery institute, on the arrangements between its JV parties, including the Medical Research Council (MRC), Cancer Research UK, the Wellcome Trust and a number of universities.
  • Bind Research, a not-for-profit Focused Research Organisation, on its establishment and funding.
  • VC funds including Epidarex Capital, ALSA Ventures, SCI Ventures and UCL Technology Fund on a number of transactions.
  • High-growth companies on a number of fundraisings, including:
    • DrDoctor, a healthtech company providing digital care solutions, on its £10m Series B fundraising led by YFM Equity Partners
    • Multus Biotechnology, a developer of growth media for cultivated meat, on its $9.5m Series A led by Mandi Ventures

Education

  • 2004 – BSc (Economics and Economic History), London School of Economics and Political Science, London
  • 2005 – Graduate Diploma in Law, Nottingham Law School, Nottingham
  • 2006 – Legal Practice Course, Nottingham Law School, Nottingham

Theo is a Partner in CMS’s Corporate Group. He advises on a wide range of corporate transactions, including acquisitions, disposals, private equity and venture capital transactions and joint venture arrangements, for both private and listed clients. Theo has a particular focus on the Life Sciences & Healthcare, Technology, Media & Communications and Sports sectors.

Clients include established domestic and international companies, growing businesses, institutional investors, high net-worth individuals and management teams.

Theo co-manages CMS’s equIP programme, which supports early/growth stage business. 

Awards & Recognitions
01
  • Quote
    "Theo Godfrey is really helpful. He explains things very well, is always available to speak with us and somehow to accommodate urgent requests. He is very friendly and helpful and very keen to ensure the best outcome for the client."
    Legal 500, 2021
  • Quote
    “Experienced, market savvy, decisive”.
    Legal 500
  • Quote
    “Always on top of her subject”
    Legal 500
  • Quote
    “First class technical knowledge and communicates effectively”

Relevant experience

  • A UK Premier League football club on its financing arrangements.
  • An Indian Premier League cricket franchisee on a number of strategic transactions
    Salary Finance, the payroll lending business, on the sale of its Work Report business to Experian.
  • Clearscore, the credit marketplace business, on its $200m investment from lnvus Opportunities.
  • Modulr, the digital payments provider, on its $19m funding round led by Highland Europe and subsequently on a $29 investment by PayPal.
  • Arm and Thales, the shareholders of Trustonic, a developer of cyber security solutions for smart phones and loT devices, on its sale to EMK Capital.
  • MXLG, a joint venture between MXC, the AlM-listed technology focused adviser and investor, and Liberty Global, the NASDAQ-listed international TV and broadband company, on its acquisition of Koris Communications, a managed telecommunications service provider.
  • JPMorgan Chase on its strategic investments in fintech companies Mosaic Smart Data, Access Fintech and H4.
  • VC funds including TempoCap, Lakestar and Tranquil Capital on a number of transactions.
  • Alpha Group, the LSE-listed FX group, on a number of transactions.
  • High-growth companies on a number of fundraisings.

Education

  • 2004 – BSc (Economics and Economic History), London School of Economics and Political Science, London
  • 2005 – Graduate Diploma in Law, Nottingham Law School, Nottingham
  • 2006 – Legal Practice Course, Nottingham Law School, Nottingham

Further reading

  • Olswang advises Content Media Corporation on its sale to Kew Media Group

  • Olswang advises German media group Hubert Burda Media on its investment in UK online retailer Notonthehighstreet.com

  • Olswang advises Munich headquartered agency on the acquisition of Seven Publishing in the UK

Insights by Theo

On the Pulse webinar series 2026 - Spring/Summer

21 Apr 2026

On the Pulse Webinar Series 2023 - Autumn

16 Nov 2023

ESG investing - a recap for the Life Sciences and Healthcare sector

22 Mar 2023 6 min read

Life Sciences - The road to recovery

10 Feb 2021 2 min read
Back to top Back to top
You will now find all Law-Now content on CMS.law